Italia markets open in 4 hours 27 minutes

TEVA Jul 2024 18.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0700-0,0400 (-36,36%)
In data: 11:47AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1100
Aperto0,0700
Denaro0,0500
Domanda0,1000
Prezzo d'esercizio18,50
Scadenza2024-07-26
Min-Max giorno0,0700 - 0,0700
Contratto - Min-MaxN/D
Volume2
Open Interest12
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.